SB1279 would create a limited telepharmacy authorization in Hawaii law for registered pharmacists who are under contract with a “covered entity” as defined by the federal 340B Drug Pricing Program. In those circumstances, a pharmacist could oversee the filling or receipt of prescriptions through telehealth and an interactive telecommunications system when the patient is located at a facility operated by the covered entity, the entity has obtained or applied to relocate a pharmacy license for that facility, and the pharmacist is not physically present at the site.
The bill also amends the existing pharmacist supervision statute in chapter 461 to make clear that the general rule requiring a registered pharmacist to be in personal and immediate charge of the pharmacy does not apply in the new telepharmacy situation created by the bill. It preserves the broader prohibition on prescription filling, compounding, or receipt during a pharmacist’s absence except where otherwise authorized by law. The measure is described as serving medically underserved patients and is tied to telehealth and federal 340B-covered facilities.
Impact
The bill would add a new section to chapter 461, Hawaii Revised Statutes, establishing a narrow exception to Hawaii’s traditional in-person pharmacist supervision requirements. It would affect registered pharmacists, pharmacies operating within or for covered entities, and patients receiving care at facilities serving medically underserved populations, particularly those participating in the federal 340B Drug Pricing Program. The bill also updates section 461-9 to cross-reference the new telepharmacy authority, thereby integrating remote prescription oversight into existing pharmacy regulation.
Sentiment
The available voting history shows clear support in committee, with unanimous 4-0 passage in both the Senate Health and Human Services Committee and the Senate Commerce and Consumer Protection Committee, each with amendments. No committee transcript is provided, so there is no recorded debate to indicate opposition or concerns in discussion. Overall, the bill appears to have been viewed favorably as a targeted access-to-care measure.
Contention
The main policy issue is the balance between expanding access through telehealth and preserving the state’s traditional requirement that a pharmacist be physically present and in immediate charge of pharmacy operations. Any concern would likely center on patient safety, supervision, and regulatory compliance in remote prescription handling, especially because the authorization is limited to specific covered entities and facilities. The amendments and narrow scope suggest lawmakers sought to address those concerns by confining the exception to medically underserved settings and federally linked entities.
Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.